- Antitrust & Global Competition
- Aviation / Helicopter Accidents
- San Francisco Asiana Airlines Flight 214 Plane Crash
- Law on International Air Disasters
- Commercial Litigation
- Consumer Protection Litigation
- Defective Products / Mass Torts
- Elder Abuse
- Employment Law
- Environmental Litigation
- False Claims / Whistleblower
- First Amendment Defense
- Intellectual Property
- Municipal & Public Entity Litigation
- Personal Injury & Wrongful Death
- Pharmaceutical Litigation
- Securities / Financial Fraud
- Shareholder Rights / Corporate Governance
Cotchett, Pitre & McCarthy, LLP has been a leader in prosecuting cases against pharmaceutical and medical device companies in complex litigation involving the manufacture, marketing and sales of drugs and medical treatments. CPM has served as lead trial counsel or co-lead counsel in major multidistrict litigation against companies such as Pfizer and Merck. CPM has brought cases involving claims for product defect, deceptive advertisement and encouraging off-label use, amongst others. CPM is well-versed in product liability law, false advertising law and the law on federal preemption.
CPM has decades of experience in achieving justice for victims in complex pharmaceutical cases. Few law firms possess the resources, skill and tenacity to litigate these difficult cases against powerful and well-funded pharmaceutical and medical device companies.
RECENT CASES OF NOTE
Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation
USDC, Northern District of California
CPM was co-lead trial counsel in the In Re: Bextra and Celebrex Mktg., Sales Practices & Product Liability Litigation, which culminated in Pfizer agreeing to pay $894 million to settle consolidated injury and class action cases related to its pain killers Bextra & Celebrex.
Vioxx Product Liability Litigation
USDC, Eastern District of Louisiana
CPM successfully represented a number of individuals who suffered medical injuries such as heart attacks and strokes after taking the prescription drug Vioxx. The drug was withdrawn from the market by its manufacturer and distributor, Merck & Co., Inc., after evidence emerged linking the drug to heart attacks, strokes, sudden cardiac death and other serious cardiovascular risks.
Fen-Phen Product Liability Litigation
Los Angeles County Superior Court
CPM served as a member of Plaintiffs Steering Committee, as well as individually representing numerous individuals who suffered serious heart disease from the ingestion of diet drugs promoted by the distributor American Home Products.